Asthenozoospermia: Cellular and molecular contributing factors and treatment strategies

被引：89
|
作者：
Shahrokhi, Seyedeh Zahra [1 ]
Salehi, Peyman [2 ]
Alyasin, Atieh [3 ]
Taghiyar, Sana [4 ]
Deemeh, Mohammad Reza [4 ,5 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Lab Med, Tehran, Iran
[2] Shahid Beheshti Hosp, Infertil Ctr, Esfahan, Iran
[3] Arak Univ, Dept Biol, Arak, Iran
[4] Nobel Lab, Androl Dept, Esfahan, Iran
[5] Tarbiat Modares Univ, Dept Clin Biochem, Fac Med Sci, Tehran, Iran
来源：
ANDROLOGIA | 2020年 / 52卷 / 02期
关键词：
apoptosis; reactive oxygen species; spermiogenesis; MITOCHONDRIAL RESPIRATORY EFFICIENCY; CAUSES MALE-INFERTILITY; SEMEN PARAMETERS; ION CHANNELS; REGULATORY MECHANISMS; SPERM MOTILITY; FIBROUS SHEATH; DIETARY SUPPLEMENTATION; CLOMIPHENE CITRATE; DOUBLE-BLIND;
D O I：
10.1111/and.13463
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
Semen sample with poor sperm motility, which called asthenozoospermia, is considered as one of the main factors contributing to male infertility. Recognition of the cellular and molecular pathways contributing to sperm motility reduction may lead to applying novel treatment strategies for overcoming low sperm motility in asthenozoospermia individuals. In this review, we intend to discuss the main causes of sperm motility reduction in asthenozoospermia and some treatment strategies used to overcome low sperm motility.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Muscle Tension Dysphagia: Contributing Factors and Treatment Efficacy
    Kang, Christina H.
    Zhang, Nan
    Lott, David G.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2021, 130 (07): : 674 - 681
  • [32] Molecular Characteristics and Risk Factors in Endometrial Cancer What Are the Treatment and Preventative Strategies?
    Ellis, Patricia E.
    Ghaem-Maghami, Sadaf
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (07) : 1207 - 1216
  • [33] Molecular and mechanical factors contributing to ductus arteriosus patency and closure
    Crockett, Stacey L.
    Berger, Courtney D.
    Shelton, Elaine L.
    Reese, Jeff
    CONGENITAL HEART DISEASE, 2019, 14 (01) : 15 - 20
  • [34] Factors contributing to outcomes in treatment foster care: Treatment parent perspectives
    Isaacs, B
    Perlman, N
    Pleydon, A
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2004, 48 : 420 - 420
  • [35] Molecular mechanisms and genetic factors contributing to the developmental dysplasia of the hip
    Zhao, Xiaoming
    Liu, Shuai
    Yang, Zhonghua
    Li, Yong
    FRONTIERS IN GENETICS, 2024, 15
  • [36] TREATMENT OF ASTHENOZOOSPERMIA BY INTRATESTICULAR TESTOSTERONE THERAPY
    FAHIM, MS
    IBRAHIM, HH
    GIRGIS, SM
    ABDALLA, MI
    AWWAD, AA
    ARCHIVES OF ANDROLOGY, 1983, 11 (01): : 81 - 84
  • [37] One goal, different strategies - molecular and cellular approaches for the treatment of inherited skin fragility disorders
    Huenefeld, Christian
    Mezger, Markus
    Kern, Johannes S.
    Nystroem, Alexander
    Bruckner-Tuderman, Leena
    Mueller, Ingo
    Handgretinger, Rupert
    Roecken, Martin
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : 162 - 167
  • [38] MOLECULAR STRATEGIES FOR THE TREATMENT OF DIABETES
    FERBER, S
    SCHNEDL, WJ
    BELTRANDELRIO, H
    IRMINGER, JC
    HALBAN, P
    NEWGARD, CB
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (02) : 363 - 365
  • [39] Contributing factors
    Shore, MF
    PSYCHIATRIC SERVICES, 2003, 54 (12) : 1600 - 1601
  • [40] Physician Perspectives on Factors Contributing to Readmissions and Potential Prevention Strategies: A Multicenter Survey
    Shoshana J. Herzig
    Jeffrey L. Schnipper
    Lauren Doctoroff
    Christopher S. Kim
    Scott A. Flanders
    Edmondo J. Robinson
    Gregory W. Ruhnke
    Larissa Thomas
    Sunil Kripalani
    Peter K. Lindenauer
    Mark V. Williams
    Joshua P. Metlay
    Andrew D. Auerbach
    Journal of General Internal Medicine, 2016, 31 : 1287 - 1293
12345